Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-25-001592
Filing Date
2025-02-25
Accepted
2025-02-25 16:11:27
Documents
1
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4372
  Complete submission text file 0001562180-25-001592.txt   5938
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Issuer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6550 SOUTH MILLROCK DRIVE SUITE G50 SALT LAKE CITY UT 84121
Business Address
Etherington Robert Dee (Reporting) CIK: 0001835330 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39834 | Film No.: 25663233